You just read:

Alpha Mannosidosis Market to be Worth US$21.8 Million by 2024: Exclusivity of Orphan Drug Ensures Improved Profit Margins, Says TMR

News provided by

Transparency Market Research

03 Jan, 2017, 06:30 ET